ZEAL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Zealand Pharma A/S

Watchlist Manager

Watchlist

Price: 296.3 DKK 0.68% Market Closed

Market Cap: kr21.2B

	Zealand Pharma A/S CSE:ZEAL	DK
	Engie SA PAR:ENGI	FR
A	Amerisourcebergen Corp LSE:0HF3	US
M	Mitsui E&S Co Ltd SWB:MU1	JP
	UBS Group AG SIX:UBSG	CH
A	Aallon Group Oyj OMXH:AALLON	FI
	Babcock International Group PLC LSE:BAB	UK
	Zhejiang Orient Financial Holdings Group Co Ltd SSE:600120	CN

Profitability Summary

Zealand Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

84%

Exceptional Operating Margin

77%

Negative 3Y Average Operating Margin

-669%

Operating Margin is Increasing

-855% > 77%

Exceptional Net Margin

70%

Negative 3Y Average Net Margin

-631%

Net Margin is Increasing

-1 187% > 70%

Exceptional Free Cash Flow Margin

70%

Negative 3Y Average Free Cash Flow Margin

-536%

Free Cash Flow Margin is Increasing

-707% > 70%

Exceptional ROE

55%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

95%

ROIC is Increasing

-228% > 864%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.